I am very pleased to announce that Stefan Terwindt has joined The Arcas Group as Executive Vice President and Principal.
Stefan is an experienced executive who brings great marketing insight, relationships and skills to our company. He will resume responsibility for the commercialization of MDoutlook and drive the continued growth of our company.
Previously, Stefan served as President of Imedex, Inc. a subsidiary of AmerisourceBergen Specialty Group, and has a 20-year career in continuing medical education, life sciences marketing and international consulting. He is multi-lingual with extensive experience working across cultures, driving change and building successful relationships at all levels within and outside an organization. Stefan holds a B.B.A. in International Business and an MBA from the University of Georgia.
“It is an amazing opportunity for me to join Jan and his team. We have successfully worked together and built businesses in the past. My focus will be on further developing MDoutlook, our unique, web-based, disease intelligence platform. MDoutlook serves a significant need of life sciences companies by improving their understanding of and connectivity with medical ThoughtLeaders and clinicians through proprietary methodologies. MDoutlook offers marketers a uniquely detailed insight into physician’s treatment decisions and motivations on a real-time basis,” says Stefan.
Our leadership team, including Stefan, will be at the upcoming ASCO from May 28 to June 2 in Orlando to meet with our clients, prospects and oncology ThoughtLeaders. We look forward to seeing you there. Please give us a call at +1.404.496.4136 to schedule a meeting.
A copy of the press release can be found here: Arcas Appoints Stefan Terwindt as Executive Vice President.